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Abstract
Minimally invasive cardiac procedures requiring a transseptal puncture are becoming
increasingly common. For cases of complex or diseased anatomy, clinicians may benefit
from using a patient-specific cardiac phantom for training, surgical planning, and the
validation of devices or techniques.
An imaging compatible cardiac phantom was developed to simulate a MitraClip ®
procedure. The phantom contained a patient-specific cardiac model manufactured using
tissue mimicking materials.
To evaluate accuracy, the patient-specific model was imaged using CT, segmented, and the
resulting point cloud data set was compared using absolute distance to the original patient
data. The phantom was validated using a MitraClip ® device to ensure anatomical features
and tools are identifiable under image guidance.
Patient-specific cardiac phantoms may allow for surgical complications to be accounted for
in pre-operative planning. The information gained by clinicians involved in planning and
performing the procedure should lead to shorter procedural times and better outcomes for
patients.
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Chapter 1
1
1.1

Introduction
Background

This chapter includes a basic introduction to the physiology of the heart and an overview
of the previous works and processes that were used to develop this thesis. With
increasing life spans due to more advanced health care, cardiovascular disease has
become the number one cause of death around the world, with one in four deaths being
attributed to cardiovascular issues and an economic impact totalling over $320.1 billion
USD [1]. Modern lifestyles have led to many people being sedentary, with jobs that
require workers to sit for prolonged periods. This has led to an increase in obesity, a
reduction in exercise, high blood pressure and poorly controlled diabetes, all which are
risk factors for cardiovascular disease.
Medical companies have developed a wide range of tools, devices, and techniques to use
as therapies to treat cardiovascular disease and prolong a patient’s life. In recent years, to
reduce the impact on a patient, these therapies have been transitioning from invasive
open-heart surgery to minimally invasive procedures. Such procedures are performed
while the heart is still beating using catheters that are inserted into the body and
manoeuvred with aid from imaging modalities.
This work was motivated by the ever-increasing complexity of minimally-invasive
cardiac procedures. As medical technology continues to progress, the rate at which new
tools and systems are coming to market is increasing. With each new procedure,
clinicians must learn the necessary skills and motor patterns to provide patients with safe
and effective care. It is our hope that the outcome of this thesis will provide clinicians
with the ability to practice these new procedures in a safe and realistic environment,
allowing them to develop the skills and confidence they require.
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1.2

The Human Heart

The human heart is a muscular organ responsible for the distribution of blood throughout
the body. The heart acts a pump, distributing oxygenated blood returning from the lungs
to the rest of the body and sending deoxygenated blood back to the lungs. To regulate
blood flow within the heart there are four chambers and four valves. The four chambers
of the heart are the left and right atria and the left and right ventricle (Figure 1). The
valves are the mitral, tricuspid, aortic and pulmonary (Figure 2).

Figure 1.1: Cardiac chambers (Image Courtesy of The Cardio Research Web Project)
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Figure 1.2: Cardiac valves (Image Courtesy of The Cardio Research Web Project)
Blood travels throughout the heart in two systems. The left side of the heart is responsible
for the distribution of oxygenated blood to the body. The oxygen rich blood returning
from the lungs enters the heart through the pulmonary veins and into the left atrium. As
the atrium contracts, the mitral valve is opened and the blood passes into the left
ventricle. When the left atrium has relaxed, the mitral valve closes preventing blood from
flowing backwards. The left ventricle then contracts, opening the aortic valve, allowing
blood to leave the heart and be distributed throughout the body. The right side of the
heart receives blood back from the body after the oxygen has been depleted and directs it
to the lungs. The deoxygenated blood returns through the inferior and superior vena cava
and enters the right atrium. As the right atrium contracts, blood passes through the
tricuspid valve and flows into the right atrium. As the right ventricle contracts, the
pulmonary valve opens and allows blood to flow back to the lungs.

1.3

Cardiac Surgery

The first successful cardiac operation was performed by Dr. Ludwig Rehn in Frankfurt
Germany in 1896 where he successfully repaired a patient’s right ventricle. Cardiac
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surgeries throughout the early 1900’s were performed by accessing the heart through an
incision in the chest cavity and operating on a beating heart. It wasn’t until 1953 when
the cardiopulmonary bypass concept was introduced that a patient could continue to have
blood flow throughout the body without the need for the heart to be beating. This allowed
for more complex procedures to be performed and led to the development of open heart
surgery.
Open heart surgery is the classifications given to procedures where the patient receives a
sternotomy in which the chest is opened and the affected cardiac anatomy can be
operated on. The patient is connected to a cardiopulmonary bypass machine, allowing the
surgeon to arrest the patient’s heart, and operate on the affected location without having
to compensate for heart’s motion. With the use of cardiopulmonary bypass machines,
cardiac surgeries were able to become more complex and effective for patients. However,
due to the need to crack the patient’s rib cage to gain access to the beating heart, there is
an increased impact to the patient and a risk of post-surgery complications.
The post-surgical risks to the patient are influenced by the body’s negative
immunological response and the potential for plaque disruption during the surgery. After
undergoing open heart surgery using a cardiopulmonary bypass machine, the body
undergoes an innate immune response that manifests as a whole body systemic
inflammatory response and can lead to a temporary immunodeficiency [2]. In addition,
when performing cardiac surgery, there is a risk of plaques becoming disrupted or
rupturing. If this is to happen, the plaque rupture can lead to the formation of a blood clot
in the artery and in severe cases, result in a stroke or heart attack.

1.4

Minimally Invasive Cardiac Procedures

To reduce the impact on patients and recovery times that are inherent with open heart
surgery, methods have been developed to access the heart using minimally invasive
techniques. These procedures rely on catheters inserted through a small incision into
specific veins and arteries within the body which allow a catheter to be manoeuvred into
the heart. These procedures are beneficial to patients as the recovery time post-surgery is
typically drastically reduced when compared to an open-heart procedure [3]. This is also
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critical for high-risk or elderly patients as they may not be physically capable of receiving
open heart repairs using a bypass machine, but may be eligible to receive a minimally
invasive repair.
When performing minimally invasive cardiac surgery, one common access point for the
catheter is the femoral vein, through which a catheter can be navigated from the femoral
vein, through the inferior vena cava, and into the right atrium. For a clinician to perform
common procedures such as atrial ablation, mitral valve repair or replacement or a
MitraClip® procedure, a catheter is used to puncture the patient’s septal wall and cross
into the left side of the heart, accessing the left atrium, left atrial appendage, mitral valve
or left ventricle.
The main limitation of these procedures is the need for clinicians to rely on medical
imaging such as ultrasound, computed tomography (CT), magnetic resonance imaging
(MRI) or fluoroscopy to interpret the patient’s anatomy and navigate the catheter while
inside the patient. In most cases, an experienced clinician can identify anatomical features
while viewed under image guidance. Difficulty may arise however if the patient’s
anatomy is highly irregular or deformed. This may hinder the clinician’s ability to
interpret the patient’s anatomy and directly impact the clinical outcome for the patient.
For very complex cases, patients can be denied care if the clinicians are unable to
interpret the preoperative imaging and develop a procedural plan.

1.4.1

Transseptal puncture

The atrial septum is the dividing wall between the left and right atria. An opening in this
wall closes during fetal development to prevent blood flow between the two chambers. A
transseptal puncture is a common component of minimally invasive cardiac procedures
that utilize the femoral vein as the access point. For a catheter to be navigated into the left
atrium, clinicians puncture the atrial septum wall to pass the catheter or tool from the
right atrium to the left. During minimally invasive procedures, navigating a catheter to
puncture the septal wall is performed under fluoroscopy and ultrasound guidance. The
tools designed for these minimally invasive procedures can require specific septal wall
puncture locations to properly orient them within the left atrium and position them at the
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target. Ensuring the septal wall puncture location is correct can greatly increase the
duration of the surgery and the radiation dose administered to a patient through
fluoroscopy use.

1.4.2

Atrial Ablation

Atrial ablation is a minimally invasive procedure used to treat atrial fibrillation, which is
an abnormal heart rhythm with periods of rapid or irregular beating. In a normal beating
heart, the electrical signals generated by the sinoatrial node are propagated to the
myocardium and cause the heart to contract. For a heart with atrial fibrillation, the signals
generated by the sinoatrial nodes are interrupted by electrical discharges occurring at the
openings of the pulmonary veins within the atria. This interference causes the heart to
beat irregularly and out of rhythm. The treatment for atrial fibrillation is commonly
radiofrequency ablation or cryoablation, in which a catheter generates scar tissue around
the area producing the electrical discharges (Figure 3). The scar tissue does not conduct
electricity and contains the electrical discharges within the ablated area. The ablation
stops the propagation of the interfering electrical signals and treats the atrial ablation.

Figure 1.2: Illustration of the atrial ablation of the pulmonary vein openings (image
courtesy of the London Arrhythmia Centre)
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1.4.3

MitraClip ®

A MitraClip ® procedure is a common minimally invasive intervention to repair a mitral
valve when it is not closing effectively and allowing blood to regurgitate from the left
ventricle back into the left atrium. Regurgitation reduces the amount of blood being
distributed to the body, resulting in an increased work load for the heart, which can lead
to cardiac remodelling or other complications. To perform a MitraClip ® procedure a
catheter is guided from the femoral vein into the right atrium, where the septal wall is
punctured and the deployment catheter (Figure: 4) can be aligned with the mitral valve.

Figure 1.3: MitraClip ® tool used for the treatment of mitral valve regurgitation (Image
Courtesy of Abbott)
Using ultrasound imaging the catheter is guided to the location of the regurgitation and a
clip(s) is deployed, holding the two leaflets of the mitral valve together while allowing
blood to pass through the valve (Figure 5).
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Figure 1.4: MitraClip ® tool aligned with the mitral valve and deployed (image courtesy
of Abbott)
If the clip is placed correctly the patient’s mitral regurgitation can be reduced or
eliminated, greatly impacting their quality of life.

1.4.4

Atrial Appendage Closure

The left atrial appendage (LAA) is a tubular hooked structure (Figure 6) connected to the
muscle wall of the left atrium. There are several common types of LAA with some
examples seen in Figure 6, however, each patient may have unique variations. In healthy
patients as the heart contracts, blood is pushed from the left atrium and LAA into the left
ventricle. When a patient has atrial fibrillation the left atrium no longer contracts
properly, which can cause blood to pool within the LAA and form blood clots. According
to the Cleveland Clinic, people who experience atrial fibrillation are 5 to 7 times more
likely to have a stroke because of a blood clot than people without atrial fibrillation [4].
Currently blood thinners are prescribed to prevent blood from clotting with the LAA,
however, there can be unfavourable side effects and consequences of the use of blood
thinners. Another approach to preventing blood clots is the use of LAA occlusions
devices such as the Boston Scientific Watchman device. This device is inserted into the
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LAA and designed to create a seal between the left atrium and the LAA. If properly sized
and deployed (Figure 7, 8) the device prevents any blood flow into the LAA and over
time tissue grows over the device creating a complete and long lasting barrier.

Figure 1.5: Common atrial appendage shapes (Image Courtesy of Boston Scientific)

Figure 1.6: Watchman Appendage Closure Device deployed inside the an atrial
appendage (Image Courtesy of Boston Scientific)
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Figure 1.7: Watchman Appendage Closure Device deployed and fully sealing the atrial
appendage opening (Image Courtesy of Boston Scientific)

1.5

Image Guidance

Image guidance refers to the different imaging modalities used in diagnostic and
therapeutic imaging. For minimally invasive procedures, clinicians rely on a combination
of preoperative and intraoperative imaging to provide visual feedback on the patient’s
anatomy and the location of tools. Preoperative imaging allows clinicians to gain a
comprehensive view of the patient’s anatomy and pathology and develop a plan for the
procedure. During the procedure, the clinician uses intraoperative imaging to navigate
and position the catheter or tool to the desired location. The preoperative imaging can be
used to supplement intraoperative imaging, ensuring the clinicians have a comprehensive
understanding of the patient’s anatomy and pathology.
Currently, several imaging modalities can be used to visual anatomy within a surgical
environment. This can include MRI, CT, fluoroscopy, ultrasound and positron emission
tomography. These modalities each have their own advantages and can be used in
combination with each other to best visualize the anatomy and tools.

1.5.1

Preoperative Image Guidance

Preoperative image guidance allows clinicians to diagnose and develop a plan for the
procedure. Clinicians perform preoperative diagnostic scans aimed at locating areas of
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interest in the patient’s anatomy and pathology. If the clinicians determine that the
pathology requires intervention, these preoperative scans can be used to plan the
operation, including the optimal route for catheter navigation, sizing of tools or devices to
be inserted into the patient, or the target location for the intervention to take place, such
as the area to be ablated. In cases where the patient’s anatomy or pathology is complex,
preoperative imaging may be difficult to interpret, making procedural planning more
difficult and leading to a higher risk to patients, or patients not receiving treatment that
they need.

1.5.2

Intraoperative Image Guidance

As minimally invasive procedures develop and increase in complexity, the need for
intraoperative imaging is becoming more important. These procedures rely on visual
feedback from imaging modalities to interpret a patient’s anatomy and locate the tool(s)
within the patient. For minimally invasive cardiac procedures, catheters need to be
navigated from common access points such as the femoral vein or the femoral artery, into
the heart and positioned near the area of interest. To navigate catheters towards the heart
from the access point, clinicians can use a combination of magnetic tracking if available,
intraoperative imaging and the preoperative images.
Commonly in minimally invasive procedures, clinicians will rely on fluoroscopy and
ultrasound for intraoperative imaging. Due to the radiation from the fluoroscopy, there is
a desire to limit its use during surgery and only use as needed, preventing clinicians from
seeing the tool in real time and only while imaging is being used. More complex
surgeries can require extra fluoroscopy to guide the catheter, increasing the radiation dose
to patients and their risk of potential long-term complications. To navigate the catheter or
tool under image guidance can require a high level of dexterity and skill as the clinician
must interpret the anatomy as it appears under image guidance and mentally map the
route for the catheter between uses of fluoroscopy.

1.6

Clinical Challenges

When relying on imaging modalities to diagnose and perform a procedure there are
several factors that can influence the clinician’s ability to perform the procedure
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effectively. The dependence on imaging modalities means the quality, age, and
calibration of the scanner can directly impact the images the clinicians see. In the surgical
planning phase, clinicians must make decisions regarding the tools and devices that are
best suited for the pathology, in addition to planning for the target location, device size,
and implementation based solely on the preoperative images. In many cases, preoperative
imaging provides sufficient information to allow clinicians to make informed decisions
and confidently perform the procedure. In cases where a patient has complex anatomy or
the disease has caused cardiac remodelling, clinicians must take extra care in planning, or
in some cases may have to refuse treatment to patients if the risk of failure is too high.
For procedures with target locations in the left atrium using the femoral vein as the access
point, such as atrial ablation or mitral valve repair, the procedure must include a septal
puncture. The ideal location of the puncture may be different for each procedure
depending on the design of the surgical tool. In the case of the MitraClip ®, the design of
the system requires the puncture to occur near the highest point of the septal wall. This is
important, as once inside the left atrium the catheter must bend adequately to align with
the mitral valve. If the initial puncture does not occur in the proper location, the clinicians
may have to perform the puncture a second time, increasing the use of fluoroscopy, the
procedure time, and the risk to the patient.
Due to variations in patient anatomy, the duration and use of fluoroscopy during a
MitraClip ® procedure can vary drastically. In a study from 2011, the average duration of
the procedure was 172.1 minutes ± 82.9 [5], a variation that can be attributed to
limitations in visualizing the septal wall under image guidance, variations in cardiac
anatomy from patient to patient or from remodelling due to disease. For complex cases,
according to clinicians, the septal wall puncture can account for up to 50% of the duration
of a MitraClip ® procedure. As the time spent on the septal puncture increases, so does
the use of fluoroscopy, increasing the dose of radiation experienced by the patient,
creating a need for improved procedural planning tools for difficult cases.
Finally, there can be difficulties sizing and properly positioning devices such as valve
replacements or atrial appendage closure devices that are to be implanted within a patient.
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In the case of the Boston Scientific Watchman atrial appendage closure device, the atrial
appendage is imaged preoperatively using ultrasound. The resulting image is used to
measure the size of the appendage and determine the optimal placement location. The
quality of the ultrasound image can greatly impact the results of the preoperative
planning. If the device is not properly sized, when implanted into a patient it may leak
and not fully block off the appendage, leading to future complications for the patient and
not resolving the patient's current issue.

1.7

Clinical Training

The goal of clinical training is to prepare clinicians with the knowledge and skills to
interact with and treat patients effectively. The training of new clinicians is commonly
approached using the, “see one, do one, teach one” method, using the assumption that a
clinician can be trained to perform a procedure through watching another clinician. The
clinician should then be able to effectively perform the procedure and subsequently teach
a new clinician. Invented by William Halsted in 1890 at John Hopkins Hospital, to
formalize the training of new clinicians, this method has remained largely unchanged and
is still the main form of training today. Despite the method’s longevity, critics have
argued that this method is no longer sufficient when used independently from simulations
[6], [7]. The authors argue that in using just the “see one, do one, teach one” method,
there is a higher level of risk for patients who will be treated by inexperienced clinicians
who may lack the skills and confidence of a more experienced practitioner. A study in
2003 found that 42% of young doctors felt inexperienced in performing a practical
surgery without supervision [8]. This finding leads to a need for more comprehensive
training for new clinicians or new procedures.
With the development of new tools and surgical techniques, there is a need for clinicians
to continue to learn and train throughout their careers. As new procedures are adopted by
hospitals, it requires clinicians to work with new tools, learn new motor patterns and
skills. It is imperative that clinicians are properly trained with the new equipment in a
realistic training environment. Currently, in addition to the “see one, do one, teach one”
method, training for new clinicians or new techniques may include the use of fresh
cadavers or animals. Cadavers offer realistic anatomy, but there is be no motion from
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respiration or blood flow. Depending on the surgical application, a live animal may be
more relevant. Animal training, typically using pigs, allows for training on an animal that
is still breathing and has blood flowing throughout the body. The anatomy of these
animals may present limitations as they do vary from humans, however, this does create a
realistic training environment. Unfortunately, due to the cost of animals or fresh
cadavers, along with ethical concerns, clinicians may still have limited training
opportunities. Thus, new procedures may be performed by clinicians who have very
limited time and training with the device and may have never performed the specific
procedure on a live human.
For new clinicians, or those performing new or infrequent procedures, there can be an
increased risk to the patient. Studies have shown a direct relationship between the volume
of procedures performed and the overall outcome for patients, with patients receiving a
procedure performed by a clinician who frequently performs the operation having a
higher chance of a positive outcome [9]–[11]. To allow for clinicians, new or
experienced, to practice in a safe, realistic and cost effective way, there needs to be a
method of supplementing the current training methodology to increase the time and
frequency that clinicians are able to spend practising.

1.8

Surgical Simulation

Surgical simulations are the imitation of a real surgical scenario. Simulations can be
performed on cadavers, animals, models or on surgical simulators. Simulators can offer
the ability to train a clinician’s skills, problem-solving or clinical judgment. The earliest
medical simulations occurred with cadavers, anatomical models and by using
standardized patients or actors. Cadavers and models allowed clinicians to practice
procedures and skills in a safe environment without putting a patient at risk, however, in
modern times these can be expensive and need to be ethically approved. When learning
bedside manner and skills for patient interactions, medical students use standardized
patients to recreate real life interactions and create clinical scenarios. These standardized
patients allow students to work with real people and develop the skills needed to
communicate and interact effectively with patients [12].
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As medical technology, has developed, more complex procedures including minimally
invasive cardiac techniques have required more complex simulations. These new
procedures required clinicians to develop new skill sets, both in navigating tools and
interpreting the patient’s anatomy through image guidance. To bring the efficacy of
simulations using standardized patients into minimally invasive surgery and expand on
the “see one, do one, teach one” method, surgical simulators can be used. Simulators can
provide a realistic training environment using generalized or patient-specific anatomy
that can be designed to be compatible with various imaging modalities. Simulators like
the LAP MENTOR TM, from 3D Systems, can offer a repeatable and safe environment in
which the clinicians can make errors and learn from mistakes while training using real
tools for laparoscopic surgery.
Development of surgical mannequins and task-specific trainers, such as CentraLineMan
from Simulab, have allowed for surgical tasks to be trained in a hands-on environment
without the need for an operating room. These trainers aim to create a realistic
environment in which the clinician develops the controls, knowledge, and decisionmaking abilities to perform the procedure effectively. Task-specific trainers have been
developed to teach clinicians a portion of a surgical procedure, an example of which is
hand-eye coordination for a laparoscopic environment using the Laparoscopic Training
Box (Laptrainer) by US Surgical or more general trainers that are designed to recreate a
surgical scenario. Simulators have been developed for ophthalmology [13], orthopaedics
[14], endovascular intervention [15], cardiac interventions [16], [17] and other
procedures [18], [19]. The literature has found that incorporating surgical simulations
into the educational process may improve clinical training and reduce negative outcomes
for patients [20], [21]. Each trainer aims to recreate a surgical scenario such that the skills
developed on the trainer can be transferred to the procedure on a patient.

1.9

Surgical Guidance Validation

In addition to creating a realistic training environment for clinicians, surgical simulators
also act as a tool for the validation of new image-guided virtual and augmented reality
techniques. To ensure these systems will accurately assist clinicians and reduce cognitive
load during surgery, they are validated and tested using accurate anatomical models. This
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can be done with cadavers, animal studies, and more recently using surgical phantoms
[22]–[24]. Surgical phantoms are designed to use patient-specific or generalized models
that allow for the interaction and/or simulation of a procedure. Surgical simulators are
ideal for the validation of augmented or virtual reality techniques as they allow the user
to precisely position the anatomical model(s), creating a gold standard. In addition, a
phantom is much more accessible and offers a solution that greatly reduces the cost and
difficulty of performing validation studies throughout development.

1.10 Models for Surgical Planning
For cases of complex anatomy and pathology, there has been an increasing acceptance
from clinicians towards the use of patient-specific models as a tool to better view and
interpret anatomy [25], [26] when preparing the pre-procedural plan. These models
typically come in two forms, as computational or physical models. The computational
models are digital renderings that can to be used for interpretation and finite element
modelling (FEM) [27], [28]. Physical models are typically created using three
dimensional (3D) printing technology [29]–[31], which allows them to be held, measured
and interacted with. In both forms, the patient’s scan is segmented and used to generate a
tessellated computer model that gives clinicians a three-dimensional perspective of the
anatomy and pathology.

1.10.1

Computational Models

Computational 3D models can be used with FEM to reproduce a surgical technique and
attempt to predict surgical outcomes prior to the surgery [32]. As this technology
continues to develop, the ability to examine different options for repair may allow
clinicians to choose the ideal repair technique for individuals based on simulated results
[32]. This could lead to more positive outcomes for patients by ensuring each patient is
receiving the best treatment available. In addition to FEM models, the computer models
can be used by clinicians to closely examine the potential pathways for catheter
navigation and to evaluate the target location for the procedure. This can be useful in
choosing the correct size of a device in a procedure such left atrial appendage closure, or
examining the fossa ovalis and measuring the proper catheter puncture location.
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1.10.2

3D Printed Models

In addition to computational models, 3D printers have made it possible to quickly and
reliably create a physical representation of a patient’s anatomy [26], [33]. Many previous
studies have examined the use of rigid 3D printed models as a preoperative planning tool
[34]–[36]. These models are becoming increasingly popular as clinicians realize the value
that three-dimensional models can add in the preoperative phase for measuring,
evaluating and interacting with the anatomy. The current state of the art allows for
models to be printed using multiple materials, giving clinicians the ability to print
anatomical features in a variety of colours, or using materials of different properties,
combining both flexible and rigid features [37], [38], [39]. Varying colours allows
anatomical features to be more easily identified, and by using materials with different
properties the models will have more realistic visual and haptic characteristics. Producing
high-quality models utilizing multiple or flexible materials can add significant cost to the
surgical workflow, as these models require the need for high-end 3D printers, which
implies either a large investment into purchasing or outsourcing to companies that charge
a premium to print.
Despite the cost, there are benefits to flexible, over rigid, models, as they are more
representative of a patient’s anatomy, and they provide some ability to interact with the
models that rigid models do not. This may include fitting surgical tools or devices into
the models or allow for a procedure to be simulated or practised on the model. With the
material properties being controlled by the manufacturer, the flexible models can be
constrained and may not be suitable for all anatomical representations. In addition, as
most of these procedures are minimally invasive, requiring the use of image guidance.
For patient-specific 3D models to be incorporated into the simulation of a surgical
procedure, these models would need to be representative of human tissue while viewed
under common imaging modalities. Currently, the state of the art flexible 3D printed
materials does not sufficiently represent human tissue under image guidance, resulting in
a need for new materials or alternative methods of producing anatomical models.
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1.10.3

Flexible Models

Therefore, to develop a patient-specific model that is both flexible and compatible for use
with common surgical imaging modalities such as ultrasound, MRI or CT, these models
need to be produced from specific materials that currently cannot currently be 3D printed.
For ultrasound applications, the material polyvinyl alcohol cryogel (PVA-C) is often used
as it can be produced to mimic the mechanical properties, the speed of sound and
attenuation of human tissue [40]. The material itself can be limited as it is 90% water,
requiring the model to be stored in a sealed container to prevent it from drying out and
shrinking.
In addition to PVA-C, many flexible silicones offer the ability to reproduce a patient’s
anatomy with a high degree of accuracy. Silicone can be highly flexible, durable and
offers a wide variety of material properties that can be modified depending on the
application. Using moulding as the manufacturing method, silicone has been used to
create flexible patient-specific models that are capable of being used as tools to analyze a
patient’s anatomy, simulate a surgical procedure or measure and size a device to be
inserted into the patient [41], [42]. Silicone has imaging properties that are dependent on
the brand and product line that is used. For use with ultrasound, silicone has higher
attenuation than cardiac tissue, but if the wall of the model is thin, then silicone may still
be suitable for the application.
The use of flexible, rather than rigid 3D printed models increases the number of potential
applications for the user. Flexible models, like rigid models, can act as useful preprocedure tools to guide clinicians, make measurements and aid in planning the
procedure. Unlike rigid models, flexible models with imaging properties representative of
human tissue may be used in applications of surgical simulation. Surgical simulators
offer great potential for the medical field. Specifically, a surgical simulator that uses
patient-specific anatomy could offer a safe and comprehensive training experience for
new or inexperienced clinicians. They can also be used to validate new surgical tools or
image guidance techniques while in the development stage, helping to reduce the need for
animal trials. Finally, they may allow for the simulation of a surgical procedure
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preoperatively, using different tools and techniques to evaluate each method’s efficacy
for the patient.

1.11 Summary
Currently, the use of 3D models, both computational and physical, can help provide extra
information in the planning stage of a procedure. Using these models clinicians can get a
better understanding of the anatomy they are operating on, helping to avoid extra
cognitive load while interpreting image guidance during a procedure. The state of the art
3D printers are able to produce models that are flexible, multi-material, and
multicoloured, which can aid in interpreting anatomical features, measuring key locations
or interacting with the patient’s anatomy. These models are still limited from a materials
standpoint, where they are not representative enough of cardiac tissue in regards to
imaging or mechanical properties. Employing materials that provide more realistic
properties for mimicking cardiac tissue may allow clinicians to better interact and use
moulded 3D models that mimic anatomical features.
Due to an increased rate of development of surgical tools, devices and techniques there is
an increasing need for clinicians to have access to systems that allow them to learn,
practice and simulate interventions. This need is emphasized in clinical evidence where
the frequency a clinician performs a procedure can directly impact the outcome of a
patient [9]. To address this concern, companies have developed physical, augmented and
virtual reality simulators that are designed to recreate surgical scenarios for training
clinicians, allowing them to receive feedback regarding their performance while learning
the motor patterns and skills for a specific procedure.
Due to the nature of minimally invasive cardiac surgery, with each procedure comes a
different set of tools, motor skills, and clinical objectives. The clinicians must be trained
using the new systems to ensure they are fully prepared to perform the procedure on a
patient. To meet training needs of clinicians, a simulator needs to be developed, that can
incorporate different catheters, tools, and devices, to allow for current and future
procedures to be practised. To ensure the surgical phantom sufficiently simulates a
procedure, the phantom should include patient-specific models with material properties
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that are representative of cardiac tissue both physically and under image guidance. This
allows clinicians to learn the motor patterns while experiencing the same cognitive load
of interpreting image guidance as when performing a real procedure. The patient-specific
model incorporated within the phantom should include all anatomical features relevant to
the procedure and the model should be interchangeable to allow for different scenarios to
be trained or to allow for a specific patient’s anatomy to be simulated.

1.12 Objective 1
At the outset of this work, there was not a concrete methodology for manufacturing
flexible patient-specific cardiac models. As there is evidence that 3D printed models can
provide clinicians with beneficial information for procedural planning, the first objective
of this thesis was to develop a methodology to produce thin walled patient-specific atrial
models using tissue mimicking materials and validate the manufacturing method for
accuracy. The methodology and results of the validation study are reported in Chapter 2.

1.13 Objective 2
Building on the results from chapter 2, it was decided the second objective would be to
further expand these models to include all clinically relevant anatomy needed to simulate
a minimally invasive procedure. These models would be utilized within a surgical
phantom that would be imaging compatible. These tools would then be evaluated for
accuracy and functionality by simulating a MitraClip ® procedure. The results of the
model development and surgical simulation are described in Chapter 3.
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Chapter 2
2

Patient-Specific Atrium Models for Training and PreProcedure Surgical Planning

2.1

Introduction

For cases of abnormal or diseased patient anatomy, the ability to view and interact with
patient-specific models in addition to being able to simulate interventional conditions
may provide valuable information for the pre-procedure plan. A review paper published
in 2016 [29] examined the results of 14 studies that used 3D printed models to help with
surgical planning for a variety of procedures involving congenital heart defects. The
consensus of this review was that the models were beneficial in planning the procedure.
Building on the work done for creating models of other cardiac anatomy, the
development of patient-specific atrial models could lead to improved clinician training,
better surgical planning, and more informed decisions, ultimately decreasing surgery
times and resulting in better outcomes for patients. In broad terms, the intent of this
investigation is to increase the amount of information that surgical teams have access to
for pre-procedure surgical planning. More specifically, we aim to create a workflow for
creating patient-specific left and right atria that have realistic tissue and imaging
properties. These models can benefit clinicians in planning particularly complex
interactions with a patient’s anatomy prior to performing any incisions. This
methodology will be used to evaluate the efficacy and feasibility of creating pre-operative
models of a patient’s left and right atria. The models will be validated to determine their
accuracy and their ability to reproduce anatomical features that are key to minimally
invasive cardiac procedures.

2.2
2.2.1

Methods
Overview

The atrial models were developed to include important anatomical features that are used
throughout surgery as access points, spatial identifiers, or potential areas of repair. This
list includes access into the atria through the inferior and superior vena cava, the atrial
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transseptal wall, the left atrial appendage, the left atrial opening for the mitral valve and
the right atrial opening for the tricuspid valve. These features ensure that the preoperative
models will contain the information needed to analyse areas of concern for a wide variety
of minimally-invasive cardiac surgeries.

2.2.2

Imaging

After REB approval, a cardiac patient’s CT data were anonymized and used for the
preparation of the atrial models. The patient was scanned using the GE Discovery CT750
HD with 64 slices and a voxel size of 0.5 x 0.5 x 0.625 mm.

2.2.3

Tissue Segmentation

The internal blood pools within the heart were segmented using the software “itk-snap”
[43] (http://www.itksnap.org) and the resulting volumes modified to only include the
blood pool within the left and right atria. The segmentations ended at the mitral and
tricuspid annuli. The blood pool models were segmented using automatic threshold
segmentation and then manually corrected to ensure all layers contained the required
anatomy. Geometric models which enclosed all the segmented voxels were then
generated to allow for the data to be modified with computer aided design (CAD)
software. The geometric models were exported in the stereolithography (STL) format
(Figure 9: Step 1).

2.2.4

Computer-aided Design STL Manipulations

The STL models were then imported into the software, MeshLab [44], where the number
of triangulated faces were reduced using decimation, and the overall model smoothed
using the Taubin Filter [45] to remove artefacts generated during the segmentation or
scanning processes.
With the models corrected, they were then modified using the computer aided design
software, SpaceClaim (http://www.spaceclaim.com) to add features (Figure 9: Step 2).
These features included: uniformly offsetting the blood pool models by 3 mm to generate
outer walls of the atria, and adding an indentation to act as the fossa ovalis (the most
common location for atrial septal wall punctures). All relevant anatomical features that
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were added to the models were identified by a clinician to ensure accuracy. Finally,
features were added to allow for the models to be 3D printed and moulded, including cutouts for the mitral and tricuspid valve annuli and alignment pegs.

2.2.5

3D Printing Technologies

The modified STL models were then printed using fused deposition modelling on the
Ultimaker 2+ 3D printer (https://ultimaker.com). Models were printed using Cura version
15.04.6. The settings used for the prints were: layer height of 0.1 mm; shell thickness 0.8
mm; 0.6mm fill for the bottom/top thickness; fill density 20%; and extruder nozzle
diameter, 0.4 mm. Support material was used everywhere as required. The models were
printed using polylactic acid (PLA) filament with a diameter of 2.85 mm. The settings
chosen for these prints were used to reduce error in the final part and replicate the
patient's anatomy as closely as possible. Printing time for all four components (inner and
outer left and right atria), was approximately 40 hours.

2.2.6

Post Processing

After the models were printed, they were post-processed to remove artefacts added by the
3D printer. The first step was to remove all the support material used during the printing
process, after which the models were sanded using low grit sand paper to remove any
small artefacts such as stepping in between layers and any material left connected after
breaking away the support structure. Next, the models were coated with Smooth-On
XTC-3D® (https://www.smooth-on.com) to assist in sealing the components and remove
any remaining stepping artefacts between layers which are generated by the 3D printer
(Figure 9: Step 3). After allowing the XTC-3D® to cure the models were then sanded
again to remove any final artefacts and to ensure an even coating of the sealant.

2.2.7

Molding

To date, there is no flexible material with material properties to adequately mimic atrial
tissue that can be directly 3D printed. Hence, to make patient-specific models from
materials that simulate the properties of cardiac tissue, the models must be moulded. To
build a mould, the rigid models representing the 3-mm offset from the blood pool
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segmentation were used as a mould positive. The moulds were created by pouring
Smooth-On Mold Star® 16 Fast silicone around the 3D printed models. This process was
performed to create a 2 or 3-part mould depending on the model complexity. Upon curing
of the silicone, the 3D printed models were removed from the mould (Figure 9: Step 4).
The 3D printed models of the internal blood pool were then inserted into the moulds and
tissue mimicking material, either silicone or polyvinyl alcohol (PVA) cryogel, was used
to make the hollow patient-specific model. The silicone material used was Smooth-On
Ecoflex® 00-30 as it has high flexibility and durability. To optimize echogenicity, the
two-part silicone is mixed and then degassed in a degassing chamber to remove any air
that has been mixed into the silicone while stirring. When it appears that all the trapped
air bubbles have been removed the material is poured into the mould and left to cure. To
produce a PVA-C model, the PVA mixture is created by dissolving 10% by weight PVA
crystals in hot (95°C) water. When the mixture has cooled, it can be poured into the
mould and the material allowed to sit, so that trapped air bubbles rise to the surface and
escape. On completion of this process, the mould is placed into a freezer at -20°C and left
to freeze for 12 hours, after which the mould can gradually warm to room temperature in
a cooler. This cycle is repeated for three freeze-thaw cycles, to create a flexible material
which exhibits a speed of sound and attenuation coefficient similar to that of cardiac
tissue, while maintaining a realistic flexibility [40]. Once the material, either silicone or
PVA-C, is fully cured, the 3D printed parts of the internal blood pools can be removed,
leaving a hollow model of patient-specific atria (Figure 9: Step 5).

2.3

Validation

Validation of the final patient-specific model was performed using a cone-beam CT
scanner. The model was scanned using a Medtronic O-Arm ® scanner with a voxel size
of 0.415 x 0.415 x 0.833 mm. The left and right atria model were held in a typical
anatomical pose using a custom 3D printed stand (Figure 9: Step 6). The stand offers
support to the model at the inferior and superior vena cava, all four pulmonary vein
openings, and employs hooks located at the mitral and tricuspid openings to reduce
sagging. The stand was developed using CAD software, and 3D printed using the same
printer and parameters as the patient-specific models. The completed high-resolution 3D
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CT scan was then segmented and used to create a geometric model (Figure 9: 7). This
model was then exported as an STL file where it was used to compare the final model to
the original patient data. Using the software program CloudCompare [46]
(www.danielgm.net/cc), the final model was registered to the original patient STL model
using the original iterative closest point algorithm [47]. The registered models were then
used to measure absolute distance between point cloud data sets (Figure 9: Step 8) to
determine the accuracy of the physical models.

Figure 2.1: Workflow showing the progression from segmentation of patient CT data to
silicone model. Step 1 is an STL model generated after segmentation of the patient’s
blood pool. Step 2 is the blood pool model smoothed and modified using computer aided
design to prepare it for 3D printing. Step 3 is a 3D printed blood pool model with
alignment pegs that are used for molding. Step 4 is the flexible silicone mold used for
generating the flexible models. Step 5 is a hollow silicone atria model. Step 6 is the
silicone model inside a 3D printed fixture that hold the model in an anatomical
orientation during CT scanning. Step 7 is the result of the CT scan of the silicone atria
model. Step 8 is the result of the comparison of the scanned silicone model to the original
patient model.
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2.4

Results

The two-point cloud models were compared using Euclidean offset distance. For this
trial, which only includes 1 patient data set, when comparing the point cloud of the
physical model to the original data set, the results have a maximum distance of 4.5 mm,
an average of 0.5 mm and a standard deviation of 0.6 mm with a full histogram of the
results seen in Figure 10. A colour map of the absolute distances between the scanned
model and the original patient data can be seen in Figures 11 and 12.
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Figure 2.2: Histogram showing the results of the Euclidean offset distance when
comparing the physical model to the original patient data set
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Figure 2.3: Distance map comparing the segmentation of the CT scan from the silicone
atria model to the segmentation of the original patient data

Figure 2.4: Cross section view of the right atrium, showing the fossa ovalis and the
results of the Euclidean distance mapping
The results of this study demonstrate the ability of this methodology to accurately
replicate a patient’s cardiac anatomy with a high degree of accuracy. Using this
methodology, models of a patient’s left and right atria could be generated as a tool for
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pre-procedure surgical planning and would act as an accurate replica of what the clinician
could expect to see during the surgery.

2.5

Discussion

We have demonstrated a methodology to accurately build patient-specific models of
cardiac atria, and which has the ability to recreate important anatomical features as seen
in a patient’s CT scan in a physical, flexible model. These models can be made from
tissue mimicking materials, such as PVA-C and silicone. For surgeries requiring the use
of ultrasound during the repair, the model can be made of PVA-C. PVA-C is a material
with variable mechanical properties depending on the number of freeze/thaw cycles, and
a speed of sound that is very similar to human tissue [48], resulting in the ability to image
the physical models and plan how to best utilise ultrasound throughout the surgery.
In addition to PVA-C, models can be made from silicone. Silicone offers a variety of
material properties, colours, and the ability to create highly detailed parts. Models made
from silicone are useful as tools for physical inspection and for testing surgical repairs.
Silicone is stable at room temperature, is long lasting and can be physically manipulated
without easily tearing. Surgical teams can use silicone models for the identification of
anatomical features, measurements and gaining visual information regarding diseased
areas. These models make it possible for clinicians to gain insight into areas of concern
due to diseased or complicated anatomy, for example by selecting the optimal size for
LAA closure, or assessing septal puncture locations for MitraClip ® delivery. This
should allow for a more informed surgical plan, which could lead to shorter surgical
times and better patient outcomes.
Many previous studies have examined the use of rigid 3D printed models as a
preoperative planning tool [34]–[36], [49]. These studies have demonstrated the value
that three-dimensional models can add in the preoperative phase. There have also been
studies examining the potential of directly 3D printing flexible models for surgical repair
simulation and as training tools [37]. These directly 3D printed models are reliant on the
material properties of what can be purchased for their 3D printers. Currently, the
materials available on the market do not have imaging properties that can adequately
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represent cardiac tissue while under ultrasound, and the printers themselves are quite
expensive. As material science evolves, it is possible that a new material will be
developed to meet this need. Currently, however, due to this limitation, we have chosen
to utilize moulding to create flexible models. This gives us the option of using
significantly more materials in creating flexible models. The ability to use PVA-C gives
us a tissue mimicking material with ultrasound properties that are very close to cardiac
tissue. It is our hope that this ability will allow for us to create patient-specific models
that are representative both visually (with ultrasound and MRI) and physically
representative of cardiac tissue.
We report a maximum error of 4.5 mm, however, these areas are primarily found in
regions where the model was sagging, as a result of the model not being properly
supported during the CT scan. A solution to this would be to change the validation
procedure to instead scan the models while they are in a neutrally buoyant solution, to
ensure the model is in the correct position without requiring specific supports. The
current workflow is labour intensive and requires upwards of 2 weeks after receiving the
data from a patient’s scan to prepare and build a heart model for one of three distinct
applications, surgical planning, as a training tool, or for validation. For surgical planning,
the current 2-week period creates a time-consuming and expensive addition to surgical
planning. For this methodology to be included, it would require optimizations that reduce
the manual labour and potential costs to hospitals. In regards to using these models as
training tools or as models for validation, the 2-week time period is acceptable. Multiple
different models can be created simultaneously, and once a mould has been completed,
models can be built with as little as an hour of labour.
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Chapter 3
3

A Patient-Specific Cardiac Phantom for Training and
Pre-Procedure Surgical Planning

3.1

Introduction

To meet the needs of clinicians and researchers, we have developed a cardiac phantom
employing patient-specific cardiac models to recreate minimally invasive cardiac
procedures. The phantom is designed to use a model of a patient’s cardiac anatomy held
within an acrylic chamber that allows clinicians to simulate cardiac procedures that
utilize the femoral vein, the femoral artery or the apex of the left ventricle as access
points. The simulator is intended to be ultrasound compatible with access for a
transesophageal echocardiogram probe to be inserted into the simulated oesophagus, in
addition to being fully compatible with MRI, CT, and fluoroscopy.
This phantom will provide the opportunity to simulate a variety of minimally invasive
cardiac procedures. These simulations can be used for testing difficult cases, training new
clinicians on basic or complex pathologies, and acting as a validation tool for new
medical devices or augmented reality guidance techniques.

3.2

Methods

The phantom was developed in three stages. First, patient-specific models were
manufactured using silicone moulding and tissue mimicking materials. Next, the valves
were produced and attached to the cardiac model. Finally, the phantom was designed and
constructed to best simulate minimally invasive cardiac procedures.
The patient-specific cardiac model was designed to include important anatomical features
that are used throughout surgery as access points, spatial identifiers, or potential areas of
repair. This list includes access into the atria through the inferior and superior vena cava,
the atrial transseptal wall, the left atrial appendage, a partial left and right ventricle and
anatomically correct mitral and tricuspid valve annuli. After moulding the cardiac wall, a
patient-specific mitral valve and a generalized tricuspid valve were manufactured and
attached to the cardiac model. These features ensure that the patient-specific models
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contain the information needed to analyze areas of concern for a wide variety of
minimally invasive cardiac procedures.
We have previously developed a methodology for creating flexible patient-specific
models using materials compatible with various imaging modalities[42]. Here we expand
on this methodology to include more complex anatomical features that are required for
the simulation of minimally invasive cardiac procedures, in addition to adding the
necessary features to allow for the model to function within the cylindrical chamber of
the phantom.

3.2.1

Imaging

As outlined in the previous chapter, the patient-specific model was produced following
REB approval, using an anonymized patient’s CT data. The patient was scanned using
the GE Discovery CT750 HD with 64 slices and a voxel size of 0.5 x 0.5 x 0.625 mm.

3.2.2

Tissue Segmentation

To maintain the critical features within the heart, the internal blood pools of the CT data
were segmented using the software 3D Slicer [50]. The segmentations were performed
using an automatic threshold in combination with manual techniques to correct any errors
on each slice. Geometric models which enclosed all the segmented voxels were then
generated to allow for the data to be modified with CAD software (Figure 13: step 1).
The geometric models were exported as an STL file.

3.2.3

Computer-aided Design STL Manipulations

Using the method outlined in 2.2.4 the models were corrected and simplified in MeshLab
[44]. The model was then imported into SpaceClaim and modified by cutting crossing the
left and right ventricle to allow for the model to be integrated into the heart phantom.
Next, the model was uniformly offset by 3 mm to generate an artificial myocardium for
the cardiac model. Finally, a flange was added to the patient-specific model, allowing it
to be connected to the phantom container in the correct orientation.
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3.2.4

3D Printing Technologies

The STL models were then printed using the printer and settings outlined in section 2.2.5.
Printing time for the components: outer cardiac model (Figure 13: step 2), inner cardiac
model (Figure 13: step 3), flange and mould container, was approximately 80 hours.

3.2.5

Post Processing

Once printing was completed all of the 3D printed components were post processed using
the same methodology as section 2.2.6.

3.2.6

Molding

Currently, the state of the art for materials that can be 3D printed do not have adequate
mechanical or imaging properties to mimic cardiac tissue. Therefore, to develop a
patient-specific cardiac model using materials that simulate cardiac tissue, the models
must be moulded. Due to the complex nature of cardiac anatomy, we have chosen to use
a flexible silicone mould (Figure 13: Step 4), that allows for the complex organic shape to
be manufactured. To build the flexible mould, a custom housing was 3D printed. The
rigid model representing the 3-mm offset from the blood pool segmentation was aligned
within the mould housing and used as a mould positive. The mould was created by
pouring Smooth-On Mold Star® 16 Fast silicone around the 3D printed model into the
3D printed mould housing. The housing was designed to have alignment features that
ensured the blood pool model and 3 mm offset model could be aligned such that the
production of all subsequent models would produce consistent results. By designing a
custom container for moulding we produced a flexible, single part mould that can
generate the patient-specific cardiac model.
When the silicone mould had cured, the 3D printed models were removed, resulting in
the negative of the outer cardiac wall (Figure 13: step 5). The 3D printed models
representing the internal blood pool were then inserted into the mould utilizing the
alignment features to ensure the models were in the correct orientation (Figure 13: step
6). Tissue mimicking materials, either silicone or PVA-C, were used to make the hollow
patient-specific model. Production of the silicone model was performed using the method
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outlined in 2.2.7, where the Ecoflex® 00-30 material, is mixed, degassed and poured into
the mould.
To produce a PVA-C model, the PVA mixture is created by dissolving 10% by weight
PVA crystals in hot (95°C) water. When the mixture has cooled, it can be poured into the
mould and the material allowed to sit, so that trapped air bubbles rise to the surface and
escape. The mould is then placed into a Test Equity 1000 Temperature Chamber in which
it goes through three freeze-thaw cycles. Each cycle ramps from room temperature to 20°C and holds for 24 hours, after which the chamber gradually warms to room
temperature, and holds for 12 hours. As this cycle is repeated the liquid PVA-C mixture
gradually changes into a flexible material which exhibits a speed of sound and
attenuation coefficient like that of cardiac tissue while maintaining a realistic flexibility
[40].
The final step in the production of both a silicone and PVA-C model is to remove it from
the mould (Figure 13: step 7). The 3D printed models of the internal blood pool are
removed from the model, leaving a hollow patient-specific cardiac model (Figure 13:
Step 8).
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Figure 3.1: Workflow showing the manufacturing of a patient-specific cardiac model.
Step 1 is the entire segmentation of the blood within the patient’s heart at the time of the
scan. Step 2 is the 3D printed thickened atria model. Step 3 is the 3D printed blood pool
model. Step 4 is the 3D printed mold container with the thickened blood pool model
aligned within. Silicone has been poured into the mold container around the 3D printed
model and has cured. Step 5 is the cured and completed silicone mold. Step 6 is the blood
pool model aligned inside the mold container with silicone poured into the mold. Step 7
is the silicone heart model completed with the 3D printed blood pool still inside. Step 8 is
the complete silicone model.

3.2.7

Valve Manufacturing

Due to imaging constraints associated with a CT scan, it can become difficult properly
visualize and segment the valves within the heart at the time of the scan. The valves act
as important landmarks and guides when imaging the heart, so it is important that the
models still contain valves to aid clinicians in interpreting the patient’s anatomy and for
guiding the catheter within the model. To overcome this, we have developed a
methodology for creating both patient-specific [51] and generalized valve models. As we
did not have a TEE scan from this patient, a different patient’s TEE scan was used to
generate a mitral valve model, with the only modification being scaling of the
computational model to fit the other patient. In addition, we have also developed a
generalized tricuspid valve using the same manufacturing methods that can be added to
the patient-specific cardiac model.
These valves are constructed using a 3D printed mould made of PLA (Figure 14: step 1).
Silicone is painted onto the mould and allowed to cure. The silicone chosen for these
models is Smooth-On Ecoflex® 00-30, as it is highly durable and flexible, resulting in
realistic valve movement within a phantom. Chordae are simulated within the valve by
including strings at key locations in the model that maintain the valve’s shape. When the
silicone has cured, the valve model can be removed from the mould by peeling the
silicone off the 3D printed part (Figure 14: step 2). Both the mitral and tricuspid valves
were added to the patient-specific model using Smooth-On Sil-Poxy, a single cure
bonding silicone (Figure 14: step 3 and 4).
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Figure 3.2: Workflow showing the manufacturing of a patient-specific valve model. Step
1 is the 3D printed valve model that is used as a mold. Step 2 is the cured silicone mitral
valve model. Step 3 is the mitral valve attached to the full silicone cardiac model. Step 4
shows the silicone mitral and tricuspid valve models inside the silicone heart model.

3.3

Phantom Design

The phantom container was designed to accommodate the patient-specific cardiac model
and allow for the simulation of minimally-invasive cardiac procedures. A part of this
process, clinicians were consulted to develop the design specifications that would ensure
the phantom would perform as required. This included tool access at common access
points large enough for a variety of catheters and compatibility with TEE ultrasound, CT,
and fluoroscopy to visualize tools and anatomical features within the model. To
accomplish this, both the phantom chamber and the model had to be made using
materials that would not cause distortion for imaging modalities. In addition, the phantom
is designed as a water-filled container to permit the use of ultrasound as an imaging
modality and to help simulate blood within a patient’s heart during a procedure.

3.3.1

Phantom materials and shape

For the phantom to be compatible with the imaging modalities used throughout a
minimally invasive cardiac procedure, it was designed to contain no metal and use
components that do not distort imaging of the patient-specific model within the chamber.
The outer cylindrical chamber and walls of the phantom were constructed using acrylic as
it does not distort the patient-specific model within the chamber. The stand used was 3D
printed using the Ultimaker 3 using PLA material, and all the fasteners used were nylon
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or plastic. The overall length of the phantom is 15.24 cm, the cylindrical container has an
outer diameter of 25.4 cm and an inner diameter of 22.86 cm as seen below in Figure 15.

Figure 3.3: Side view of the cardiac phantom container with outer and inner dimensions

3.3.2

Access Points

The phantom container was designed to have 5 access points into the cardiac model at
strategic locations. The access points are located at the inferior and superior vena cava,
right and left ventricle and in line with the aortic arch. These locations can be used to
simulate catheter insertion locations for cardiac procedures or as locations for flow to be
added to the phantom. Each access point is capable of accommodating tools up to 1.47
cm in diameter and will fit all catheters up to and including 40 French (Figure 16). The
phantom container also has access for a TEE probe to be inserted into a simulated
oesophagus. Within the phantom there are two options for the oesophagus, a rigid acrylic
tube, or a flexible PVA-C model, which constrain the movement of the probe within the
phantom and to provide realistic material properties to the oesophagus.
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Figure 3.4: Cardiac phantom container access points and dimensions

3.3.3

Model Accommodation

The patient specific model is held within the phantom using a series of 8 nylon screws.
Each screw connects the flange of the model to the wall of the phantom securing it in
place. A 3D printed interfacing component applies uniform pressure onto the model
flange helping to maintain the position of the cardiac model throughout a simulated
procedure (Figure 17). The model itself is contained entirely within the phantom
container. In use, the phantom is filled with water, which helps to prevent the model from
sagging due to gravity and maintains the anatomical position.
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Figure 3.5: The full cardiac phantom with the silicone patient-specific model contained
inside

3.4

Validation of the Model

Validation of the final patient-specific model was performed using a cone-beam CT
scanner. The model was scanned using a Medtronic O-Arm ® scanner with a voxel size
of 0.415 x 0.415 x 0.833 mm. The model was scanned within the phantom container,
positioned as it would be for a simulation. The material properties of silicone were
sufficiently stiff to keep the model from sagging noticeably and to hold it in a stable
position. The completed high-resolution 3D CT scan was then segmented and used to
create a geometric model. This model was then exported as an STL file where it was used
to compare the final model to the original patient data. Using the software program
CloudCompare [46] the final model was registered to the original patient STL model
using the original iterative closest point algorithm [47], as seen in Figure 18 where the
blue model is the reference and the red model is the scanned silicone model. The
registered models were then used to measure absolute distance between point cloud data
sets (Figure 19) to determine the accuracy of the physical models.
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Figure 3.6: The segmentation of the original patient data registered or the segmentation
of the CT scanned silicone cardiac model. Blue is the original data set and red is the
silicone cardiac model.

3.4.1

Validation of the Phantom

The phantom was validated to determine its ability to realistically display anatomical
features and surgical instruments within the phantom. For the phantom to accurately
represent a heart during a cardiac procedure, the imaging parameters, including tool
visualization need to be correct. This was performed by replicating a MitraClip ®
procedure and positioning the tool at important landmarks for the procedure. The
procedure was simulated using a Medtronic O-Arm ® scanner for both CT and
fluoroscopy, and the model was also viewed under TEE ultrasound guidance using the
Phillips iE33 Ultrasound machine. Images were acquired by an experienced anaesthetist
who simulated the standard views used during a MitraClip ® procedure. The tool was
manipulated by an Abbott Canada MitraClip ® representative who is experienced in the
use and positioning of the tool. The device was positioned and imaged at the septal wall
and within the left atrium of the model. The images acquired from the simulator were
evaluated qualitatively and compared to patient images used in the Abbott Canada
MitraClip ® training guide.

3.5

Results

To verify the accuracy of the cardiac model, the two-point cloud models were compared
using Euclidean offset distance. For this trial, which only includes 1 patient data set,
when comparing the point cloud of the physical model to the original data set, the results
have a maximum distance of 7.7 mm, an average of 0.98 mm and a standard deviation of
0.91 mm with a full histogram of the results seen in Figure 19.
A colour map of the absolute distances between the scanned model and the original
patient data can be seen in Figure 20.
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Figure 3.7: Histogram showing the results of the Euclidean offset distance between the
silicone model and the original patient data set

Figure 3.8: Results of the Euclidean distance comparison between the silicone and
reference model
When comparing the ultrasound and fluoroscopy images of the cardiac model within the
simulator to the training images from Abbott Canada, there are some key points to note.
The tool is clearly visible within the cardiac model at the key points evaluated, across the
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septal wall, and within the left atrium. This ensures that the tool will be visible during a
simulated procedure and will provide realistic visual feedback for the clinician.
As the tool is manoeuvred through the femoral vein to the inferior vena cava and into the
right atrium the clinician begins to track the tool using ultrasound guidance. Upon entry
into the right atrium, the tool is aligned with the fossa ovalis to puncture the atrial septal
wall. In a MitraClip ® procedure, the tool must puncture the septal wall at a targeted
position to allow for sufficient space within the left atrium to bend the catheter and align
the tool head with the mitral valve.
The images were acquired without the use of a septal wall puncture catheter, the
MitraClip ® introducer, or sheath. This resulted in some disparity in the images at the
septal wall. Although the introducer and sheath are not present, the MitraClip ® tool head
and catheter are visible under image guidance across the septal wall (Figure 21). This is
useful for cases of septal wall puncture as a clinician would be able to both identify the
fossa ovalis and a catheter under image guidance to perform a simulated septal puncture.
The tool was visible under ultrasound guidance within the phantom on both sides of the
septal wall. This results in sufficiently realistic imaging and catheter guidance within the
phantom for replication a septal puncture from an imaging perspective.

Figure 3.9: Comparison of the MitraClip ® tool under ultrasound image guidance
crossing septal wall (right), to and image from the Abbott training manual (left) of a tool
cross the septal wall of a patient
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Once across the septal wall, the clinician manoeuvres the tool to position it in line with
the valve. To do this they must able to see the tool within the left atrium and identify the
location of the tool’s graspers. This enables the clinicians to align the tool with the
flailing leaflet. When evaluating the phantom, the tool was placed within the left atrium
and the graspers of the tool were opened. Both arms of the MitraClip ® are visible and
identifiable under ultrasound (Figure 22) and fluoroscopy imaging (Figure 23).

Figure 3.10: Comparison of the MitraClip ® tool under ultrasound guidance within the
left atrium of the silicone phantom (right), to an ultrasound image from a MitraClip ®
procedure with the tool within the patient’s left atrium (left)
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Figure 3.11: Comparison of the MitraClip ® tool under fluoroscopy guidance in the left
atrium of the silicone cardiac phantom (right) and an image from the Abbott training
manual (left) of the intervention being performed on a patient
The simulated procedure ended prior to deploying a clip onto the valve to maintain the
integrity and usability of the tool, as it can only be deployed once. The results of this
study demonstrate the ability of this methodology to accurately replicate a patient’s
cardiac anatomy with a high degree of accuracy and simulate under image guidance a
minimally invasive cardiac procedure. Using this methodology, a patient-specific cardiac
model can be generated as a tool for pre-procedure surgical planning and would act as an
accurate static replica of what the clinician could expect to see during the surgery.

3.6

Discussion

We have demonstrated a methodology to accurately build patient-specific models of
cardiac anatomy that can be used within a surgical phantom for simulation of minimally
invasive cardiac procedures. The cardiac model recreates important anatomical features
as seen in the patient’s CT scan in a physical, flexible form. These models can be made
from tissue mimicking materials such as PVA-C and silicone, allowing the user to control
the material properties of the model. In the simulated procedure employing a MitraClip ®
tool, we have shown the ability to display anatomical features that are compatible with
ultrasound and fluoroscopy imaging. This allows the phantom to be used as a simulator
with patient-specific models, a training tool for imaging or clinicians, and as a means for
validating new image-guided techniques.
Patient-specific models made from tissue mimicking materials could make it possible for
clinicians to gain insight into areas of concern due to diseased or complicated anatomy,
for example by selecting the optimal size for a left atrial appendage closure device, or
assessing septal puncture locations for MitraClip ® delivery prior to a surgery. Clinicians
have the ability to fully examine, plan, and test fit devices within the models prior to
performing a procedure. Furthermore, employing these models in combination with a
surgical phantom allows clinicians to simulate and practice the procedure. Used as a
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surgical planning tool these models may allow for a more informed surgical plan, which
could lead to shorter surgical times and better patient outcomes.
The model was scanned and validated within the chamber to evaluate the efficacy of the
phantom to accurately support and maintain the model's functionality during use. To fully
demonstrate the accuracy of the manufactured model, it could be scanned with the 3D
printed blood pool inside the flexible silicone. This would ensure the model was being
supported as effectively as possible, but would not demonstrate the accuracy of the model
within the phantom. We report a maximum error of 7.7 mm; however, this offset distance
is primarily found in areas where the model was sagging, because of the model not being
entirely supported during the CT scan.
The use of surgical phantoms in replicating minimally invasive cardiac procedures is a
developing field that aims to provide the opportunity to recreate the experience of a
minimally invasive procedure outside of the operating room. This ability will allow for
clinicians learning or maintaining their skill level to work on a phantom and hone their
skills without any risk to patients or the need for animals. In addition, this allows for a
measure of quality control between hospitals where the number of procedures performed
may be drastically different. There is evidence that the frequency at which a clinician
performs a procedure can directly impact the outcome for a patient[9]. Allowing
clinicians to train using a realistic surgical phantom may help to bridge the skill gap
between institutions, and help to provide better and more consistent care for patients.
As surgical phantoms are increasingly used as simulators and training tools, the number
of patient-specific models will increase. This will result in a catalogue of models with
varying anatomy and pathologies. Training clinicians can develop their skills, learning on
common models and working up to abnormal or atypical cases that may be very rare to
experience in the operating room. Ultimately surgical phantoms could provide the
clinicians with a training environment that allows them to experience complex surgical
scenarios with no risk to patients.
The phantom was made to accommodate a wide range of heart sizes, allowing it to be
compatible with a range of pathologies and models. Thus, to prepare a model for
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simulation, training or validation, the limiting factor is the manufacturing time of the
silicone or PVA-C model. Using the current workflow, the time required to manufacture
the patient-specific cardiac model requires upwards of 2-weeks from the time we receive
the patient’s scan. For surgical planning, the current workflow of 2-weeks is within the
typical time frame between a patient’s scan and the surgery. Although labour intensive,
developing these models for patients with complex pathologies may provide clinicians
with the information they need to perform the procedure. For clinical training and
validation, the time to produce the models is sensitive. Using the current workflow,
multiple different models can be created simultaneously, and once a mould has been
completed, models can be built with as little as an hour of labour.
This work describes our workflow for manufacturing patient-specific cardiac models and
the validation of a patient-specific cardiac phantom to be used by clinicians for training,
pre-procedure surgical planning and the validation of tools and image guidance
techniques. These cardiac phantoms aim to allow for clinicians to work with cardiac
models outside of the operating room, for procedure simulation and in a training
environment. The use of patient-specific cardiac models within heart phantom will help
to promote new research that aims to enhance minimally invasive cardiac surgeries,
making them more efficient and effective.
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Chapter 4
4

Conclusions and Future Work

4.1

Conclusions

The purpose of this thesis was first to develop a methodology for manufacturing patientspecific cardiac models using tissue mimicking materials, and second to use these models
within a cardiac phantom to allow clinicians to train, simulate procedures and validate
new tools and systems. The thesis was therefore divided into two chapters based on the
objectives stated in Chapter 1. The conclusion of both chapters are discussed hereafter.
In Chapter 2, we outlined a methodology for creating patient-specific left and right atria
models from pre-operative CT scans. This methodology has the ability to create flexible
models that have material properties similar to cardiac tissue and can accurately represent
the patient’s anatomy. It is our hope that these models will help to provide clinicians with
more information in the pre-procedure surgical planning phase. In cases of difficult
anatomy, these models may be able to provide the necessary information to allow for
adequate planning and preparation to avoid potential risks and harms to the patient.
In chapter 3 we presented a methodology for building patient-specific cardiac models
from pre-operative CT scans and the incorporation of them into a cardiac phantom. Using
this methodology, we have demonstrated the ability to simulate a minimally invasive
cardiac procedure by performing a MitraClip ® intervention using a patient-specific
cardiac model. The phantom is capable of the visualization of surgical instruments within
the cardiac model, in addition to providing a simulation environment sufficient for the
training of minimally invasive procedures and surgical planning. It is our hope that this
cardiac simulation system will provide, new clinicians the opportunity to train using
surgical tools in a realistic surgical environment, with both basic and complex models. In
addition, the simulator can be used by researchers to test and validate new image guided
techniques and augmented reality systems. Finally, we hope to see the simulator used in
pre-procedure planning for cases where a patient would not be eligible to receive
treatment due to their complex anatomy or pathology.
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4.2

Future Work

Medical simulators have the potential to allow for clinical training for new and
experienced clinicians in ways that have not been possible for minimally invasive
surgery. The availability of simulators may allow new clinicians to develop confidence
and skills with surgical tools without the need for animal or cadaver studies, which would
drastically impact ethical concerns and the cost of training. Clinicians can learn from
mistakes and develop strategies and skills through repetition that are not possible with
current training opportunities.
For minimally invasive cardiac procedures, we have demonstrated the ability to design
and produce a cardiac simulator capable of simulating minimally invasive cardiac
techniques. To further increase the realism and power of the simulation, there are several
areas of future work that could improve the simulation or the time required to produce a
patient-specific model.
The current manufacturing methodology for producing the patient-specific model using
the tissue mimicking materials is labour and time intensive. There is great promise with
3D printing to quickly produce patient-specific models, with the state of the art being
able to do so using flexible materials. To bring 3D printing to the development of these
models, it will require new material science to develop a flexible and imaging compatible
material that can be 3D printed or to develop a 3D printing system capable of 3D printing
with the currently used materials, silicone, PVA-C, agar or ballistics gel. The ability to
produce a new patient’s model directly on a 3D printer would allow for the generation
and adaptation of a patient’s model to the current simulator within 48 hours of receiving
the patient’s scan.
Other future work includes the adaptation of the static cardiac model into a dynamic
state. The current phantom is designed to allow for flow to be added to the system at key
locations within the model to create realistic mitral and tricuspid valve motion. This is
highly important as the valves within the system currently act as spatial identifiers for
clinicians, and their motion allows them to be more easily located under ultrasound
guidance, aiding clinicians in interpreting anatomical features within the heart. With the
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current phantom design, the access ports allow for connection to a reciprocating pump
that provides suction and outflow, such that when integrated with the phantom, should
allow for valve motion within the patient’s model.
Additionally, the simulator could be further enhanced with the use of tool tracking and
augmented reality to provide clinicians with feedback regarding the tools locations within
the phantom and/or the optimal tool path to follow. Augmented reality could be used as a
training tool to help interpret the tools location, target, and the patient’s anatomical
features under image guidance. As the user’s skills advance, these augmented aids could
slowly be reduced, greatly lowering the barrier to entry for new clinicians and allowing
the clinician to develop and work on specific skill sets. By integrating tool tracking, the
clinician's tool path, puncture location or device placement could be evaluated against the
ideal location, providing useful feedback to the user, allowing them to improve and learn
from each training session.
Each area of future work is aimed at improving the user’s experience when working with
the simulator. Currently we have demonstrated that the phantom can be used as a training
tool, however, there are many avenues to improve the phantom and develop systems that
can improve the training experience. I hope that this thesis has laid the ground work for
further developments in surgical simulation and patient-specific modelling, such that
future research can build on this work and continue to develop tools and systems that will
aid in clinical training, pre-procedure planning and system validation.
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